Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-09-30FDA Approved: ACETAZOLAMIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original application for acetazolamide, enabling a generic version of the drug to be manufactured and …
-
FDA approval · 2016-05-05FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Betaxolol hydrochloride submitted by Sandoz Inc, updating the product labeling.
-
FDA approval · 2016-04-19FDA Approved: BIMATOPROST — Original Application (Sandoz Inc)
FDA approved the original ANDA for bimatoprost ophthalmic solution by Sandoz, establishing a generic version of this glaucoma medication.
-
FDA approval · 2016-01-19FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc, resulting in changes to the product's labeling…
-
FDA approval · 2015-11-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
The FDA approved Advagen Pharma Ltd.'s supplemental application for dorzolamide hydrochloride, authorizing a generic version of the drug.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-10FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc under NDA 020816, reflecting an approved modification t…
-
FDA approval · 2015-11-05FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
The FDA approved a supplemental application to market IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) under Harrow Eye, LLC. T…
-
FDA approval · 2015-11-05FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc.
-
FDA approval · 2015-10-15FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for COMBIGAN (brimonidine tartrate, timolol maleate) submitted by Allergan, Inc., updating the produ…
-
FDA approval · 2015-10-08FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated.
-
FDA approval · 2015-10-06FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
The FDA approved a supplemental application for Timolol Maleate from Pacific Pharma, Inc., under an approved supplemental submission.
-
FDA approval · 2015-07-20FDA Approved: BIMATOPROST — Original Application (Apotex Corp.)
FDA approved the original application for bimatoprost from Apotex Corp, granting approval for a generic ophthalmic solution. Bimatoprost is …
-
FDA approval · 2015-07-10FDA Approved: TRAVOPROST — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s original application for Travoprost, a generic eye drop used to lower intraocular pressure in glaucoma and o…
-
FDA approval · 2015-05-11FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for betaxolol hydrochloride from Sandoz Inc.
-
FDA approval · 2015-02-23FDA Approved: MIOSTAT — Supplemental Application (Alcon Laboratories, Inc.)
The FDA approved a supplemental application for MIOSTAT (carbachol) filed by Alcon Laboratories, Inc.
-
FDA approval · 2014-12-19FDA Approved: ACETAZOLAMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original application for acetazolamide from Heritage Pharmaceuticals (Avet) as a generic drug product.
-
FDA approval · 2014-11-25FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost from Mylan Pharmaceuticals Inc., supporting a generic latanoprost product. This …
-
FDA approval · 2014-11-18FDA Approved: BRIMONIDINE TARTRATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved Brimonidine tartrate from Florida Pharmaceutical Products, LLC under an Original Application (ANDA), enabling its entry as a ge…
-
FDA approval · 2014-09-25FDA Approved: MITOSOL — Supplemental Application (Mobius Therapeutics LLC)
The FDA approved a supplemental application for MITOSOL (mitomycin C) from Mobius Therapeutics LLC. The approval expands its ophthalmic labe…
-
FDA approval · 2014-09-25FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Brimonidine Tartrate filed by Sandoz Inc. The document does not specify the exact scope of t…
-
FDA approval · 2014-09-19FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for LUMIGAN (bimatoprost).
-
FDA approval · 2014-09-03FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Original Application (Indoco Remedies Limited)
FDA approved Indoco Remedies Limited's generic dorzolamide hydrochloride-timolol maleate ophthalmic solution for lowering intraocular pressu…
-
FDA approval · 2014-04-03FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental NDA for LATANOPROST submitted by Mylan Pharmaceuticals Inc. The approval pertains to latanoprost, a therapy used…
-
FDA approval · 2014-03-12FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, indicating a modification or addition to th…
-
FDA approval · 2014-02-28FDA Approved: PHOSPHOLINE IODIDE — Supplemental Application (Fera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Phospholine Iodide (echothiophate iodide ophthalmic solution) by Fera Pharmaceuticals, LLC.